Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback